On this page
Evidence dossier
The report behind the claim
The study reported reduced acute injury measures and evidence implicating KLF4 in the laboratory response. The work does not establish cancer-treatment compatibility or long-term patient safety.
Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Irradiated mice and rat liver-derived cultured cells
- Endpoint
- Liver enzymes, injury, lipid accumulation and KLF4-related experiments
- Finding on record
- The study reported reduced acute injury measures and evidence implicating KLF4 in the laboratory response.
- Limits of inference
- The work does not establish cancer-treatment compatibility or long-term patient safety.
The experiment in view
The study used irradiated mice and rat liver-derived cultured cells. Its principal measures were liver enzymes, injury, lipid accumulation and KLF4-related experiments. The study reported reduced acute injury measures and evidence implicating KLF4 in the laboratory response.
Reading the result closely
Protecting nonmalignant liver tissue during an experiment is not evidence that adding a compound during cancer care is beneficial overall. Tumor response, treatment interactions and long-term outcomes would require their own study. A proposed molecular mediator is not a clinical selection test.
The boundary of the finding
The work does not establish cancer-treatment compatibility or long-term patient safety.
Related evidence, kept separate
BPC-157 in a skin alkali-burn and cell study examines wound closure, tissue remodeling and cell proliferation/migration. Here, the measured endpoint was liver enzymes, injury, lipid accumulation and KLF4-related experiments. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with The paracetamol rat model does not establish a human overdose antidote appraisal.
On the record
The documents supporting this report.